Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: J Hepatol. 2022 Nov 8;78(2):238–246. doi: 10.1016/j.jhep.2022.10.027

Fig. 2. Boxplots showing the relationship between changes in adipose depot volumes and histologic improvement in NASH.

Fig. 2.

Relationships (A) between change in sSAT and histologic improvement in NASH (P = 0.911, Wilcoxon test); (B) change in dSAT and histologic improvement in NASH (P = 0.030, Wilcoxon test); (C) change in VAT and histologic improvement in NASH (P = 0.031, Wilcoxon test); (D) change in sSAT, dSAT and VAT for different degrees of change of lobular inflammation score (Spearman’s correlation ρ = −0.1, P = 0.399; ρ = 0.04, P = 0.737, and ρ = 0.21, P = 0.066, respectively); (E) change in sSAT, dSAT and VAT for different degrees of change of portal inflammation score (Spearman’s correlation ρ = −0.13; P = 0.265, ρ = −0.03, P = 0.789, and ρ = −0.15, P = 0.19, respectively); (F) change in sSAT, dSAT and VAT for different degrees of change of hepatocellular ballooning score (Spearman’s correlation ρ = 0.13, P = 0.252; ρ = 0.28, P = 0.015, and ρ = 0.16, P = 0.173, respectively). dSAT, deep subcutaneous adipose tissue; NASH, non-alcoholic steatohepatitis; sSAT, superficial subcutaneous adipose tissue; VAT, visceral adipose tissue.